Invest in the new standard of care in medical vein treatments
Invest in the new standard of care in medical vein treatments
Issuer:
(Canadian Special Purpose Acquisition Corp.)
(“CSPAC”)
Sole purpose to raise capital and complete a Go-Public business combination transaction
with Israel based operating company
Min. Investment
* Price Per Unit
Min. Units
* Unit includes one common share @ $0.56 and one purchase warrant with term of 2 years to purchase one common share at price of $0.84 per share.
108 provides curated high-quality source of early to mid-stage investment opportunities.
Focusing on high-growth tech businesses, our offerings have:
